Hong Kong Asia Medical Group
PrivateLast Round
Series D
Feb 10, 2022
Total Funding Raised
$585M
Company Overview
Hong Kong Asia Medical Group is a healthcare company that operates a network of cardiovascular-focused hospitals and cardiac centers across Mainland China, Hong Kong, and Japan, providing clinical treatment, patient care, research, and education.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hong Kong Asia Medical Group Comparables
Compare Hong Kong Asia Medical Group with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 哈特瑞姆心脏医疗集团 | 79% | |
| IHH Healthcare Berhad | 78% | |
| United Family Healthcare | 71% |
For institutional investors. Book with your work email.
Hong Kong Asia Medical Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Feb 10, 2022 | ||||
| Growth Equity | Sep 18, 2018 | ||||
| VC Round | Jan 12, 2017 | ||||
| Series A | Mar 1, 2016 | ||||
| Debt | Dec 8, 2014 |
For institutional investors. Book with your work email.
Hong Kong Asia Medical Group Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agricultural Bank of China International | Series D |
| International Finance Corporation | Debt |
| ICBC International Holdings Limited | Series D |
| Legend Capital | Series D |
| Country Garden Ventures Capital | Series D |
| BOCOM International Holdings Company Limited | Series D |
| Hudson Bay Capital Management | Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 10, 2022
$400M round led by Primavera Capital Group
- Sep 18, 2018
$150M round led by General Atlantic.
For institutional investors. Book with your work email.
Hong Kong Asia Medical Group Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hong Kong Asia Medical Group's valuation, stock price, and market status.
Is Hong Kong Asia Medical Group a public or private company?
Hong Kong Asia Medical Group is a private company.
What is the current stock price of Hong Kong Asia Medical Group?
Hong Kong Asia Medical Group is a private company, so its shares have no public market price. Caplight tracks Hong Kong Asia Medical Group's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hong Kong Asia Medical Group worth (valuation)?
Valuation information for Hong Kong Asia Medical Group is not publicly available.
Can I buy Hong Kong Asia Medical Group stock?
Hong Kong Asia Medical Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hong Kong Asia Medical Group's last funding round?
Hong Kong Asia Medical Group's most recent funding round was Series D on February 10, 2022.
Who are the main investors in Hong Kong Asia Medical Group?
Key investors in Hong Kong Asia Medical Group include International Finance Corporation, Country Garden Ventures Capital, HongShan Capital Group (HSG), Primavera Capital Group, General Atlantic.
Will Hong Kong Asia Medical Group IPO soon?
No public IPO plans have been announced for Hong Kong Asia Medical Group.
How can I track Hong Kong Asia Medical Group secondary market activity?
Caplight tracks bids, offers, and trades in Hong Kong Asia Medical Group's shares on secondary markets.